NCT06073574 - CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

March 31, 2021

Primary Completion Date

March 31, 2026

Study Completion Date

April 30, 2026

Conditions

Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Interventions

DIAGNOSTIC_TEST

Cardiac MRI

MRI Scans as specified in the corresponding arm group.

Trial Locations (11)

Hospital Universitario Puerta de Hierro, Majadahonda

Azienda Ospedale Università di Padova, Padua

Azienda Ospedaliero - Universitaria Careggi, Florence

Oregon Health and Science University, Portland

Brigham and Women's Hospital, Boston

Synexus - Scotland Clinical Research Centre, Bellshill

Synexus Midlands Clinical Research Centre, Birmingham

Synexus - Wales, Cardiff

Royal Free London NHS Foundation Trust, London

Richmond Pharmacology, London

Synexus - Manchester Clinical Research Centre, Manchester